日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation

基线IPSS-M评分与移植前风险降期作为接受异基因移植的MDS患者的预后决定因素

Aguirre, Luis E; Kim, Haesook T; Elmariah, Hany; Frumm, Stacey M; Kelkar, Amar H; Ho, Vincent; Gooptu, Mahasweta; Koreth, John; Shapiro, Roman M; Romee, Rizwan; Nikiforow, Sarah; Antin, Joseph H; Soiffer, Robert J; Shimony, Shai; Luskin, Marlise R; Garcia, Jacqueline S; Chen, Evan C; Wadleigh, Martha; Winer, Eric S; Stone, Richard M; DeAngelo, Daniel J; Al Ali, Najla; Sallman, David; Kuykendall, Andrew; Sweet, Kendra; Lancet, Jeffrey E; Padron, Eric; Chan, Onyee; Xie, Zhuoer; Cutler, Corey S; Komrokji, Rami S; Stahl, Maximilian

Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML

长期随访及eprenetapopt联合阿扎胞苷治疗TP53突变型MDS/AML患者的II期联合试验结果

Sallman, David A; Komrokji, Rami S; Dezern, Amy E; Sebert, Marie; Garcia-Manero, Guillermo; Rahmé, Ramy; Winer, Eric S; Lehmann-Che, Jacqueline; Roboz, Gail J; Madelaine, Isabelle; Sekeres, Mikkael A; Peterlin, Pierre; Chan, Onyee; Beyne-Rauzy, Odile; Kuykendall, Andrew; Recher, Christian; McLemore, Amy; Stamatoullas, Aspasia; Zhang, Ling; Willems, Lise; Mo, Qianxing; Raffoux, Emmanuel; Nardelli, Lisa; Berthon, Céline; Al Ali, Najla H; Quesnel, Bruno; Padron, Eric; Kantarjian, Hagop M; List, Alan F; Ades, Lionel; Lancet, Jeffrey E; Fenaux, Pierre; Cluzeau, Thomas

Response to luspatercept can be predicted and improves overall survival in the real-life treatment of LR-MDS

在真实世界中,对鲁帕西普的反应可以预测,并且能够改善低危骨髓增生异常综合征(LR-MDS)患者的总体生存期。

Consagra, Angela; Lanino, Luca; Al Ali, Najla H; Aguirre, Luis; Xie, Zhuoer; Chan, Onyee; Andreossi, Gloria; Raddi, Marco G; Rigodanza, Luca; Sanna, Alessandro; Mattiuz, Giorgio; Tofacchi, Elena; Amato, Cristina; Tanturli, Michele; De Pourcq, Sven; Walker, Alison; Kuykendall, Andrew; Lancet, Jeffrey; Padron, Eric; Sallman, David A; Restuccia, Francesco; Perego, Alessandra; Ubezio, Marta; Fattizzo, Bruno; Riva, Marta; Maggioni, Giulia; Campagna, Alessia; Della Porta, Matteo G; Santini, Valeria; Komrokji, Rami S

Clinical correlation and prognostic impact of cytogenetic clone size for myelodysplastic syndromes/neoplasm

细胞遗传学克隆大小与骨髓增生异常综合征/肿瘤的临床相关性及预后影响

Xie, Zhuoer; Al Ali, Najla; Zhang, Ling; Papenhausen, Peter; Volpe, Virginia Olivia; Chan, Onyee; Kuykendall, Andrew; Yun, Seongseok; Walker, Alison; Sweet, Kendra; Lancet, Jeffrey E; Padron, Eric; Sallman, David A; Komrokji, Rami S

A comparative assessment of molecular-based prognostic models in CMML

CMML分子诊断预后模型的比较评估

Aguirre, Luis E; Al Ali, Najla; Ball, Somedeb; Jain, Akriti G; Sallman, David A; Kuykendall, Andrew T; Walker, Alison R; Sweet, Kendra; Lancet, Jeffrey E; Padron, Eric; Komrokji, Rami S

Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes

基于临床和基因组的决策支持系统,用于确定骨髓增生异常综合征患者异基因造血干细胞移植的最佳时机

Tentori, Cristina Astrid; Gregorio, Caterina; Robin, Marie; Gagelmann, Nico; Gurnari, Carmelo; Ball, Somedeb; Caballero Berrocal, Juan Carlos; Lanino, Luca; D'Amico, Saverio; Spreafico, Marta; Maggioni, Giulia; Travaglino, Erica; Sauta, Elisabetta; Meggendorfer, Manja; Zhao, Lin-Pierre; Campagna, Alessia; Savevski, Victor; Santoro, Armando; Al Ali, Najla; Sallman, David; Sole, Francesc; Garcia-Manero, Guillermo; Germing, Ulrich; Kroger, Nicolaus; Kordasti, Shahram; Santini, Valeria; Sanz, Guillermo; Kern, Wolfgang; Platzbecker, Uwe; Diez-Campelo, Maria; Maciejewski, Jaroslaw P; Ades, Lionel; Fenaux, Pierre; Haferlach, Torsten; Zeidan, Amer M; Castellani, Gastone; Komrokji, Rami; Ieva, Francesca; Della Porta, Matteo Giovanni

Risk prediction for clonal cytopenia: multicenter real-world evidence

克隆性血细胞减少症风险预测:多中心真实世界证据

Xie, Zhuoer; Komrokji, Rami; Al Ali, Najla; Regelson, Alexandra; Geyer, Susan; Patel, Anand; Saygin, Caner; Zeidan, Amer M; Bewersdorf, Jan Philipp; Mendez, Lourdes; Kishtagari, Ashwin; Zeidner, Joshua F; Coombs, Catherine C; Madanat, Yazan F; Chung, Stephen; Badar, Talha; Foran, James; Desai, Pinkal; Tsai, Charlton; Griffiths, Elizabeth A; Al Malki, Monzr M; Amanam, Idoroenyi; Lai, Catherine; Deeg, H Joachim; Ades, Lionel; Arana Yi, Cecilia; Osman, Afaf E G; Dinner, Shira; Abaza, Yasmin; Taylor, Justin; Chandhok, Namrata; Soong, Deborah; Brunner, Andrew M; Carraway, Hetty E; Singh, Abhay; Elena, Chiara; Ferrari, Jacqueline; Gallì, Anna; Pozzi, Sara; Padron, Eric; Patnaik, Mrinal M; Malcovati, Luca; Savona, Michael R; Al-Kali, Aref

Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis.

8号染色体三体定义了由MYC-Alarmin轴驱动的骨髓增生性肿瘤的一个独特亚型

Vincelette Nicole D, Yu Xiaoqing, Kuykendall Andrew T, Moon Jungwon, Su Siyuan, Cheng Chia-Ho, Sammut Rinzine, Razabdouski Tiffany N, Nguyen Hai V, Eksioglu Erika A, Chan Onyee, Al Ali Najla, Patel Parth C, Lee Dae H, Nakanishi Shima, Ferreira Renan B, Hyjek Elizabeth, Mo Qianxing, Cory Suzanne, Lawrence Harshani R, Zhang Ling, Murphy Daniel J, Komrokji Rami S, Lee Daesung, Kaufmann Scott H, Cleveland John L, Yun Seongseok

Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia

低危骨髓增生异常综合征进展模式:预测进展为高危骨髓增生异常综合征和急性髓系白血病的因素

Jain, Akriti G; Ball, Somedeb; Aguirre, Luis; Al Ali, Najla; Kaldas, David; Tinsley-Vance, Sara; Kuykendall, Andrew; Chan, Onyee; Sweet, Kendra; Lancet, Jeffrey E; Padron, Eric; Sallman, David A; Komrokji, Rami

Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML

继发性急性髓系白血病(AML)特异性突变与ELN预后良好型NPM1突变型AML的不良预后相关。

Chan, Onyee; Al Ali, Najla; Tashkandi, Hammad; Ellis, Austin; Ball, Somedeb; Grenet, Justin; Hana, Caroline; Deutsch, Yehuda; Zhang, Ling; Hussaini, Mohammad; Song, Jinming; Yun, Seongseok; Talati, Chetasi; Kuykendall, Andrew; Padron, Eric; Walker, Alison; Roboz, Gail; Desai, Pinkal; Sallman, David; Sweet, Kendra; Komrokji, Rami; Lancet, Jeffrey